Bibliome.ai browser hg19
Search
About
Stats
FAQ
ERBB2 c.2692C>G ;(p.R898G)
Variant ID: 17-37881622-C-G
NM_004448.2(
ERBB2
):c.2692C>G;(p.R898G)
This variant was identified in 2 publications
View GRCh38 version.
Variant-Specific Resource Links:
gnomAD v2.1.1
Mutalizer Name Checker
Google
UCSC Genome Browser
ClinVar
dbSNP
Publications:
Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines.
Molecular Oncology
Keller, Simone S; Zwingenberger, Gwen G; Ebert, Karolin K; Hasenauer, Jan J; Wasmuth, Jacqueline J; Maier, Dieter D; Haffner, Ivonne I; Schierle, Katrin K; Weirich, Gregor G; Luber, Birgit B
Publication Date: 2018-04
Variant appearance in text: ERBB2: R898G
PubMed Link:
29325228
Variant Present in the following documents:
MOL2-12-441-s001.pdf
View BVdb publication page
Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer.
Oncotarget
Arienti, Chiara C; Zanoni, Michele M; Pignatta, Sara S; Del Rio, Alberto A; Carloni, Silvia S; Tebaldi, Michela M; Tedaldi, Gianluca G; Tesei, Anna A
Publication Date: 2016-04-05
Variant appearance in text: HER2: R898G
PubMed Link:
26919099
Variant Present in the following documents:
Main text
oncotarget-07-18424.pdf
View BVdb publication page